Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis

Quistrebert, J (author)

Hassler, S (author)

Bachelet, D (author)

show more...

Mbogning, C (author)

Musters, A (author)

Tak, PP (author)

Wijbrandts, CA (author)

Herenius, M (author)

Bergstra, SA (author)

Akdemir, G (author)

Johannesson, M (author)

Karolinska Institutet

Combe, B (author)

Fautrel, B (author)

Chollet-Martin, S (author)

Gleizes, A (author)

Donnellan, N (author)

Deisenhammer, F (author)

Davidson, J (author)

Hincelin-Mery, A (author)

Donnes, P (author)

Fogdell-Hahn, A (author)

Karolinska Institutet

De Vries, N (author)

Huizinga, T (author)

Abugessaisa, I (author)

Saevarsdottir, S (author)

Karolinska Institutet

Hacein-Bey-Abina, S (author)

Pallardy, M (author)

Broet, P (author)

Mariette, X (author)

show less...

 (creator_code:org_t)

Elsevier BV, 2019

2019

English.

In: Seminars in arthritis and rheumatism. - : Elsevier BV. - 1532-866X .- 0049-0172. ; 48:6, s. 967-975

Related links:

https://www.scienced...

show more...

http://kipublication...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)